Nirsevimab protects infants against RSV-linked hospitalization
Nirsevimab is efficacious for preventing hospitalization for respiratory syncytial virus (RSV)-associated lower respiratory tract infection among infants, according to a study published in the Dec. 28 issue of the New England ...
Dec 29, 2023
0
0